Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis

Francoise Macari, Marina Landau, Pascal Cousin, Barukh Mevorah, Sarah Brenner, Renato Panizzon, Daniel F. Schorderet, Daniel Hohl, Marcel Huber

Research output: Contribution to journalArticlepeer-review


Erythrokeratodermia variabilis (EKV) is an autosomal dominant keratinization disorder characterized by migratory erythematous lesions and fixed keratotic plaques. All families with EKV show mapping to chromosome 1p34-p35, and mutations in the gene for connexin 31 (Cx31) have been reported in some but not all families. We studied eight affected and three healthy subjects in an Israeli family, of Kurdish origin, with EKV. After having mapped the disorder to chromosome 1p34-p35, we found no mutations in the genes for Cx31, Cx31.1, and Cx37. Further investigation revealed a heterozygous T→C transition leading to the missense mutation (F137L) in the human gene for Cx30.3 that colocalizes on chromosome 1p34-p35. This nucleotide change cosegregated with the disease and was not found in 200 alleles from normal individuals. This mutation concerns a highly conserved phenylalanine, in the third transmembrane region of the Cx30.3 molecule, known to be implicated in the wall formation of the gap-junction pore. Our results show that mutations in the gene for Cx30.3 can be causally involved in EKV and point to genetic heterogeneity of this disorder. Furthermore, we suggest that our family presents a new type of EKV because of the hitherto unreported association with erythema gyratum repens.

Original languageEnglish
Pages (from-to)1296-1301
Number of pages6
JournalAmerican Journal of Human Genetics
Issue number5
StatePublished - 2000
Externally publishedYes


Dive into the research topics of 'Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis'. Together they form a unique fingerprint.

Cite this